Author: Penzak S.R.
Publisher: Adis International
ISSN: 1175-3277
Source: American Journal of Cardiovascular Drugs, Vol.2, Iss.2, 2002-02, pp. : 91-106
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Reports of COX-2 inhibitor-associated arrhythmias in NZ
Reactions Weekly, Vol. 1, Iss. 1076, 2005-01 ,pp. :
Aromatase Inhibitor-Associated Bone Loss: Clinical Considerations
By Pant Shubham Shapiro Charles L.
Drugs, Vol. 68, Iss. 18, 2008-01 ,pp. :
Metabolic Complications Associated with HIV Protease Inhibitor Therapy
By Nolan D.
Drugs, Vol. 63, Iss. 23, 2003-01 ,pp. :
Dual protease inhibitor therapy in the management of the HIV-1
Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 7, 2000-12 ,pp. :
Protease inhibitor (PI)-containing HAART is associated with a reduced bone mineral density
Reactions Weekly, Vol. 1, Iss. 1185, 2008-01 ,pp. :